Globus Medical, Inc. reaffirmed revenue guidance for the full year 2024. The Company reaffirms its full year 2024 revenue guidance range of $2.450 billion to $2.475 billion and fully diluted non-GAAP earnings per share range between $2.68 to $2.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.11 USD | +0.78% | +1.96% | +25.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.93% | 9.06B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.73% | 42.5B | |
+15.58% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024